These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38351181)

  • 1. The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors.
    Bergin CJ; Zouggar A; Mendes da Silva A; Fenouil T; Haebe JR; Masibag AN; Agrawal G; Shah MS; Sandouka T; Tiberi M; Auer RC; Ardolino M; Benoit YD
    Nat Cancer; 2024 Mar; 5(3):463-480. PubMed ID: 38351181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
    Bergin CJ; Zouggar A; Haebe JR; Masibag AN; Desrochers FM; Reilley SY; Agrawal G; Benoit YD
    Oncogene; 2021 Feb; 40(6):1191-1202. PubMed ID: 33323965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response.
    Luo CW; Wang JY; Hung WC; Peng G; Tsai YL; Chang TM; Chai CY; Lin CH; Pan MR
    Radiother Oncol; 2017 Sep; 124(3):395-402. PubMed ID: 28351524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway.
    Cha ST; Tan CT; Chang CC; Chu CY; Lee WJ; Lin BZ; Lin MT; Kuo ML
    Nat Cell Biol; 2016 Sep; 18(9):993-1005. PubMed ID: 27525719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
    Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
    Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G9a Is SETting the Stage for Colorectal Oncogenesis.
    Bergin CJ; Benoit YD
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32512705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.
    Liu S; Ye D; Guo W; Yu W; He Y; Hu J; Wang Y; Zhang L; Liao Y; Song H; Zhong S; Xu D; Yin H; Sun B; Wang X; Liu J; Wu Y; Zhou BP; Zhang Z; Deng J
    Oncotarget; 2015 Mar; 6(9):6887-901. PubMed ID: 25749385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.
    Zhou M; Zhang X; Liu C; Nie D; Li S; Lai P; Jin Y
    Oncogene; 2021 May; 40(20):3564-3577. PubMed ID: 33931742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of G9a in cancer stemness and promises as a therapeutic target.
    Haebe JR; Bergin CJ; Sandouka T; Benoit YD
    Oncogenesis; 2021 Nov; 10(11):76. PubMed ID: 34775469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis.
    Tachibana M; Sugimoto K; Nozaki M; Ueda J; Ohta T; Ohki M; Fukuda M; Takeda N; Niida H; Kato H; Shinkai Y
    Genes Dev; 2002 Jul; 16(14):1779-91. PubMed ID: 12130538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
    Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
    J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer.
    Pangeni RP; Yang L; Zhang K; Wang J; Li W; Guo C; Yun X; Sun T; Wang J; Raz DJ
    Clin Epigenetics; 2020 Jun; 12(1):88. PubMed ID: 32552834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin-STAT3-G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression.
    Chang CC; Wu MJ; Yang JY; Camarillo IG; Chang CJ
    Cancer Res; 2015 Jun; 75(11):2375-2386. PubMed ID: 25840984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.
    Choi S; Yoo YJ; Kim H; Lee H; Chung H; Nam MH; Moon JY; Lee HS; Yoon S; Kim WY
    Biochem Biophys Res Commun; 2019 Oct; 519(1):100-105. PubMed ID: 31481234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR.
    Yin C; Ke X; Zhang R; Hou J; Dong Z; Wang F; Zhang K; Zhong X; Yang L; Cui H
    FASEB J; 2019 Dec; 33(12):14036-14050. PubMed ID: 31647887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
    Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
    Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer.
    Chae YC; Kim JY; Park JW; Kim KB; Oh H; Lee KH; Seo SB
    Nucleic Acids Res; 2019 Feb; 47(4):1692-1705. PubMed ID: 30535125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell biological profiling of reprogrammed cancer stem cell-like colon cancer cells maintained in culture.
    Hirashima K; Yue F; Kobayashi M; Uchida Y; Nakamura S; Tomotsune D; Matsumoto K; Takizawa-Shirasawa S; Yokoyama T; Kanno H; Sasaki K
    Cell Tissue Res; 2019 Mar; 375(3):697-707. PubMed ID: 30284085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The secretome of colon cancer stem cells contains drug-metabolizing enzymes.
    Emmink BL; Verheem A; Van Houdt WJ; Steller EJ; Govaert KM; Pham TV; Piersma SR; Borel Rinkes IH; Jimenez CR; Kranenburg O
    J Proteomics; 2013 Oct; 91():84-96. PubMed ID: 23835434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.